ISPO

Symposium Presidents' Awards for Scientific Excellence

The following poster presentations from our 2002 symposium have received the Symposium Presidents' Award for Scientific Excellence.

Saturday, February 9

Session Title Presenter
Chromosomal Aberrations
Honorable Mention
Disruption of the RanBP17/Hox11L2 region by recombination with the TCR delta locus in acute lymphoblastic leukemias with t(5;14)(q34;q11). JWG Janssen, PhD
Gene Expression, Part 1
Winner
Peptide mimotopes of Tumor Associated Carbohydrate Antigens mediate anti-tumor cellular responses. T Kieber-Emmons
Gene Expression, Part 1
Honorable Mention
Methylation status of E-cadherin gene and its correlation to histological grade of malignancy in adenoid cystic carcinoma S Maruya, MD
Gene Therapy, Part 1
Winner
The role of PTEN gene therapy in bladder cancer HB Grossman, MD
Gene Therapy, Part 1
Honorable Mention
Restoration of an impaired TGF-β1 autocrine growth-inhibitory circuit using a gene transfer approach results in growth inhibition of some epithelial cancer cell lines. Z Zeinoun, MS
Chromatin Structures
Honorable Mention
Prognostic value of single micrometastatic cells detected in bone marrow of prostate cancer patients D Weckermann, MD
Viral Oncogenesis
Winner
Distribution of high-risk HPV types in Yugoslav women with cervical neoplasm Z Magic, MD, PhD

Sunday, February 10

Session Title Presenter
Carcinogenesis
Winner
Mucinous carcinoma of the colon in TGFβ1-deficient mice T Doetschman, PhD
Carcinogenesis
Honorable Mention
Analysis of gastric mutations frequency induced by Helicobacter pylori during long term chronic infection in mice. E Touati
Metastasis
Winner
Cleavage of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis? GWM Swart, PhD
Metastasis
Honorable Mention
Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis S Seto, MD
Risk Assessment, Part 1
Winner
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 carriers. P Ghadirian, PhD
Risk Assessment, Part 1
Honorable Mention
BRCA2 and genetic instability VP Yu, MA,MB, PhD
Apoptosis - Molecular Mechanisms
Winner
Apoptosis in HEP2 cells treated with etoposide and colchicine E Rudolf
Apoptosis - Molecular Mechanisms
Honorable Mention
G-CSF withdrawal-induced apoptosis of neutrophils following systemic chemotherapy for patients with recurrent breast cancer Y Ogawa, MD, PhD
Apoptosis - Molecular Mechanisms
Honorable Mention
Autocrine signaling through Ras regulates cell survival activity in human glioma cells: a potential crosstalk between Ras and PI3K-Akt pathway K Sakata, MD
Prevention
Honorable Mention
Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas S Zhong, PhD
Prevention
Honorable Mention
Inhibition of tumor cell invasion by the a3 chain of type IV collagen S Pasco, PhD
Dietary Influences
Honorable Mention
Solution structure of the 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP)-C8-dG adduct opposite dC in a DNA duplex BE Hingerty, PhD

Monday, February 11

Session Title Presenter
Angiogenesis
Winner
Anaplastic and differentiated thyroid carcinoma express different profiles of angiogenic stimuli and inhibitors GL Francis, MD PhD
Gene Therapy, Part 2
Honorable Mention
IN VIVO targeted transfection of IL-3 gene into murine haematopoietic progenitor cells through CD117 A Chapel
Familial and Hereditary Cancer
Winner
Preventive genetic screening for detection of inherited medullary thyroid carcinoma (MTC): outcome of the five years program M Wiench, PhD
Environment and Occupation
Honorable Mention
Common genetic variants of TP53 and BRCA2 in esophageal cancer patients and healthy individuals from low and high risk areas of northern China PR Taylor, MD, ScD
Environment and Occupation
Honorable Mention
Evaluation of potential genotoxic effects of three drinking water disinfectants using plant tests. C Zani
Gene Expression, Part 2
Honorable Mention
Differential gene expression in estrogen receptor negative breast cancer cells transfected with cDNA for estrogen receptor N Ros, MSc
Novel Therapies, Part 1
Honorable Mention
Novel Drug Resistance-associated Protein and new plant derived modulators for overcoming drug resistance in human tumor cells C Ramachandran, PhD
Novel Therapies, Part 1
Winner
The tyrosine kinase inhibitor sti571 downregulates gene expression by reducing histone h4 acetylation and histone deacetylase (hdac) expression. G Brusa, PhD
Novel Therapies, Part 1
Honorable Mention
Prevention of radiation-induced pulmonary fibrosis by blockade of transforming growth factor-beta (TGF-β) signaling A Nishioka, MD
Predictive Markers
Winner
Expression of human Telomerase Reverse Transcriptase (hTERT) mRNA in tumor cells from urine, as tumor marker for monitoring both relapse and urothelial microdissemination in bladder carcinoma E Caso, MD, PhD
Predictive Markers
Honorable Mention
Clinical impact of circulating tumor cells (CTC) morphological and molecular (β catenin mutations) characterization in patients with hepatocellular carcinoma P Paterlini-Brechot
Predictive Markers
Honorable Mention
Microvascular Changes During Inhibition of Colorectal Liver Metastases by SMANCS/Lipiodol. D Kuruppu, PhD

Tuesday, February 12

Session Title Presenter
Diagnostic Markers
Honorable Mention
A rapid FISH diagnosis of Ph (+) acute lymphoblastic leukemia on bone marrow and peripheral blood smears A Gaworczyk, MD
Diagnostic Markers
Honorable Mention
The hKLK3 gene coding for the tumour marker PSA (Prostate-specific antigen) is a multiply spliced gene. Y Courty, PhD
Autoimmunity
Honorable Mention
Regulatory CD8+ T cells control autoreactive CD4+ clones in healthy subjects M Molteni, PhD
Stem Cell Biology
Honorable Mention
Bone marrow homing heptapeptide bears homology to CD84 PS Becker, MD, PhD
Prognostic Markers
Winner
Reliability assessment of soluble c-erbB-2 concentrations in the saliva of healthy women and men. CF Streckfus, DDS
Prognostic Markers
Honorable Mention
Proteomic analysis of beta-catenin during the neoplastic progression from precursor lesions to invasive squamous cell carcinoma of the esophagus M Roth, MD
Prognostic Markers
Honorable Mention
Mutational alterations of connexin 43 associated with advanced stage of progression of human colon cancer VA Krutovskikh, MD PhD
Immunotherapy
Honorable Mention
Anti-idiotypic antibodies induced by genetic immunization are directed exclusively against combined VL/VH determinants: implications on the mechanism of protection M Cesco-Gaspere
Novel Therapies, Part 2
Winner
Survival of colorectal cancer patients with high levels of sialyl lewis-x and sialyl lewis-a epitope expression on tumor cells was improved by cimetidine S Matsumoto, MD, PhD